Breaking News Instant updates and real-time market news.

PCG

PG&E

$7.78

-3.2 (-29.14%)

, XLNX

Xilinx

$92.78

2.31 (2.55%)

07:35
10/11/19
10/11
07:35
10/11/19
07:35

Unusual call flow in option market yesterday

Notable call activity was cited Thursday in PG&E (PCG), Xilinx (XLNX), Philip Morris (PM), Gilead (GILD), and WestRock (WRK).

PCG

PG&E

$7.78

-3.2 (-29.14%)

XLNX

Xilinx

$92.78

2.31 (2.55%)

PM

Philip Morris

$77.67

0.22 (0.28%)

GILD

Gilead

$63.25

1.28 (2.07%)

WRK

WestRock

$35.40

1.4 (4.12%)

  • 17

    Oct

  • 23

    Oct

  • 24

    Oct

  • 06

    Nov

  • 07

    Nov

  • 10

    Nov

  • 10

    Nov

  • 12

    Nov

  • 20

    Nov

  • 07

    Jan

PCG PG&E
$7.78

-3.2 (-29.14%)

10/10/19
MSCO
10/10/19
NO CHANGE
Target $16
MSCO
Equal Weight
PG&E ruling raises uncertainty in bankruptcy process, says Morgan Stanley
Morgan Stanley analyst Stephen Byrd said that Judge Dennis Montali's decision to terminate PG&E's exclusive right to advance a plan of reorganization increases the uncertainty in the bankruptcy process, noting that the competing plan advanced by creditors would leave "very little equity value." The analyst, who believes PG&E's ability to negotiate with the victims groups and build support for its own plan will be a key driver of the stock from here, keeps an Equal Weight rating and $16 price target on the shares.
10/01/19
LEHM
10/01/19
NO CHANGE
Target $10
LEHM
Equal Weight
PG&E price target lowered to $10 from $14 at Barclays
Barclays analyst Eric Beaumont lowered his price target for PG&E to $10 from $14 after updating his valuation methodology to reflect the recently announced settlements and align more closely with the company's $14B equity rights framework. To reflect "numerous unpredictable and material variables" for the outstanding common equity, the analyst reiterates an Equal Weight rating on PG&E. However, he sees the rights offering as being attractive to current holders, assuming the termination clauses as outlined, and believes the framework "provides a path to how an upside scenario may play out."
09/18/19
SBSH
09/18/19
NO CHANGE
Target $81
SBSH
Buy
Citi ups Edison International price target to $81, says wildfire risk priced in
Citi analyst Praful Mehta reiterated a Buy rating on Edison International (EIX) and raised his price target on the stock to $81 from $78, citing his view that the shares are undervalued given the company's strong growth, good safety and operational practices and strong management even with a relatively conservative approach on valuing the company's wildfire risk. California peer PG&E (PCG) is making good progress towards a June 2020 exit from bankruptcy, though if it does not exit in time Edison does have increased risk since the size of the wildfire fund for the 2020 season will shrink significantly, Mehta tells investors.
10/11/19
SBSH
10/11/19
DOWNGRADE
Target $5
SBSH
Sell
PG&E downgraded to Sell from Neutral at Citi
Citi analyst Praful Mehta downgraded PG&E to Sell from Neutral with a price target of $5, down from $12. The stock closed Thursday down 29%, or $3.19, to $7.79. After Judge Montali terminated PG&E's exclusive right to advance a plan of reorganization, Mehta sees a 75% chance of the stock going to zero. PG&E's goal of a tough negotiation stance with the tort claims committee backfired, says the analyst. He believes the company will now likely push for claim estimation given its limited ability to get into bidding war to settle with the TCC. Mehta assigns a 25% probability of PG&E getting its plan selected, a rights offering at $20 per share.
XLNX Xilinx
$92.78

2.31 (2.55%)

10/01/19
KEYB
10/01/19
NO CHANGE
KEYB
KeyBanc makes four Semiconductor rating changes after trip to Asia
KeyBanc analyst Weston Twigg made four rating changes in the Semiconductors space after his quarterly trip to Asia revealed overall demand trends, while still weak, "are not getting worse." The analyst was encouraged to find inventories are beginning to normalize and that expectations are for normal seasonality in Q4. As a result, he upgraded Analog Devices (ADI), Microchip (MCHP), and NXP Semiconductors (NXPI) to Overweight from Sector Weight. Conversely, the China insourcing trends at Huawei and other manufacturers are accelerating faster than Twigg had expected, which results in his downgrade of Xilinx (XLNX) to Sector Weight from Overweight. The analyst also recommends building long-term positions in semi-cap and memory stocks like KLA-Tencor (KLAC), Teradyne (TER), Micron Technology (MU), MKS Instruments (MKSI), Entegris (ENTG), Applied Materials (AMAT) and Lam Research (LRCX). Lastly, Twigg says that initial demand for Apple's (AAPL) new iPhone "appears to be slightly worse than expected."
10/01/19
KEYB
10/01/19
DOWNGRADE
KEYB
Sector Weight
Xilinx downgraded to Sector Weight from Overweight at KeyBanc
KeyBanc analyst John Vinh downgraded Xilinx to Sector Weight from Overweight.
10/01/19
10/01/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Celanese (CE) downgraded to Neutral from Buy at Goldman Sachs with analyst Robert Koort citing valuation. 2. Welltower (WELL) downgraded to Equal Weight from Overweight at Barclays with analyst Steven Valiquette citing valuation. 3. Xilinx (XLNX) downgraded to Sector Weight from Overweight at KeyBanc. 4. Public Storage (PSA) downgraded to Underperform from In Line at Evercore ISI. 5. Thor Industries (THO) downgraded to Neutral from Buy at Northcoast with analyst Brandon Rolle saying he views shares as "fairly" valued following yesterday's rally and would get more constructive if there was evidence of improving North American retail demand and market share stabilization. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/02/19
RHCO
10/02/19
NO CHANGE
Target $105
RHCO
Hold
Xilinx price target lowered to $105 from $127 at SunTrust
SunTrust analyst William Stein lowered his price target on Xilinx (XLNX) to $105 and kept his Hold rating, saying that he prefers market leader Nvidia (NVDA) in the compute arena for server acceleration. The analyst still sees Xilinx as an "excellent company" that is well positioned to deliver high returns and profitable growth over time, but he prefers a more opportune entry point during this "downturn part" of the cycle.
PM Philip Morris
$77.67

0.22 (0.28%)

10/01/19
10/01/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Ericsson (ERIC) upgraded to Buy from Hold at Canaccord with analyst Michael Walkley saying since the Q2 earnings report, Ericsson has announced deals with Nex-Tech, RINA, and KDDI, demonstrating continuing 5G momentum. 2. VMware (VMW) upgraded to Outperform from Market Perform at Wells Fargo with analyst Philip Winslow saying investors have been concerned that growing interest in deploying containerized applications into Kubernetes-centric environments will eventually reduce customer demand for VMware's virtualization-centric product portfolio. 3. Tradeweb Markets (TW) upgraded to Overweight from Equal Weight at Barclays with analyst Jeremy Campbell saying recent weakness in the shares "seems largely technical," which presents an "attractive upside opportunity." 4. Scotts Miracle-Gro (SMG) upgraded to Neutral from Underperform at BofA/Merrill with analyst Christopher Carey saying the bar on the company's earnings consensus may be "too low." 5. Philip Morris (PM) upgraded to Buy from Neutral at BofA/Merrill with analyst Lisa Lewandowski citing the suspended merger discussions with Altria (MO) amid the heightened risk for U.S. vaping category following reports of lung health concerns. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/26/19
WELS
09/26/19
NO CHANGE
WELS
Wells Fargo not surprised Philip Morris, Altria Group ended merger talks
Wells Fargo analyst Bonnie Herzog says that while she is dismayed by the announcement that Philip Morris (PM) and Altria (MO) have ended merger talks, she is not all that surprised given the length of negotiations and the litany of negative FDA/health headlines throughout. The analyst expects the stocks to trade up sharply since "clearly the market wasn't in favor of this combination." Herzog adds that it appears to her the talks fell apart over JUUL and the companies announced they have agreed to focus on launching iQOS in the U.S. "as part of their mutual interest to achieve a smoke free future." The analyst continues to believe Philip Morris/Altria have a competitive advantage, especially in this environment, with iQOS. She continues to "strongly recommend" both stocks, with Philip Morris remaining her top stock pick.
10/01/19
BOFA
10/01/19
UPGRADE
Target $96
BOFA
Buy
Philip Morris upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Lisa Lewandowski upgraded Philip Morris (PM) to Buy with a price target of $96 after the suspended merger discussions with Altria (MO) amid the heightened risk for U.S. vaping category following reports of lung health concerns. The analyst notes that the whole industry may be impacted by uncertainty around vaping, but she sees Philip Morris rising above the "noise" due to its lack of vaping exposure, strong underlying fundamentals, and potential for offering alternatives to vaping products.
10/01/19
BOFA
10/01/19
UPGRADE
BOFA
Buy
Philip Morris upgraded to Buy from Neutral at BofA/Merrill
GILD Gilead
$63.25

1.28 (2.07%)

09/10/19
MSCO
09/10/19
INITIATION
Target $200
MSCO
Overweight
Galapagos resumed with an Overweight at Morgan Stanley
Morgan Stanley analyst Matthew Harrison resumed coverage of Galapagos (GLPG) with an Overweight rating and $200 price target. The analyst believes Galapagos is well positioned for success following the transaction with Gilead (GILD). He believes Gilead offers a "strong partner" to drive the company's "broad" pipeline while building commercial operations in Europe. Filgotinib will drive near-term upside in Galapagos shares while its greater than $5B cash position provides downside protection, Harrison tells investors in a research note.
07/30/19
PIPR
07/30/19
NO CHANGE
Target $75
PIPR
Neutral
Gilead's Biktarvy impressive but near-term acceleration needed, says Piper
Piper Jaffray analyst Tyler Van Buren keeps his Neutral rating and $75 price target on Gilead after its "good" Q2 results and raised outlook for FY19 product sales. The analyst notes that the launch of Bikvarty continues to be "impressive", though its performance offsets declines in other antiviral products. Van Buren adds that Gilead's revenue stability is "comforting", but he prefers to see some near-term acceleration, which he contends is possible with filgotinib expected to be submitted by year-end.
10/04/19
JEFF
10/04/19
NO CHANGE
Target $95
JEFF
Buy
Gilead shares have 'little downside' at these levels, says Jefferies
Jefferies analyst Michael Yee continues to like Gilead Science as a "long-term turnaround story" and he thinks the stock has "little downside" at between $60 and $65. While the approval of Descovy for HIV prevention came with a narrower than hoped label, it shouldn't hurt Gilead's ability to switch patients before Truvada goes generic around fall 2020, Yee tells investors in a research note. As such, he believes the company's existing $2.5B-plus franchise is protected. The analyst reiterates a Buy rating on Gilead with a $95 price target.
07/29/19
07/29/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Ericsson (ERIC) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Alexander Duval citing his view that its fundamentals are solid in Networks, Digital Services and Managed Services but the stock has pulled back by about 5% relative to the others in EU Tech since the company's Q2 report on July 17. 2. AB InBev (BUD) upgraded to Buy from Neutral at BofA/Merrill with analyst Fernando Ferreira saying the cycle of downward earnings revisions is coming to an end. 3. Volaris (VLRS) upgraded to Overweight from Equal Weight at Barclays with analyst Pablo Monsivais saying he sees share upside given the company's "simple model" that drives the lowest possible costs. 4. NXP Semiconductors (NXPI) upgraded to Outperform from In Line at Evercore ISI. 5. Gilead (GILD) upgraded to Top Pick from Outperform at RBC Capital with analyst Brian Abrahams saying the stock represents a "compelling opportunity" with limited downside risks as the company's HIV franchise generates a "steady" annual revenue of about $16B per year over the medium term given the "very strong" uptake of its Biktarvy, according to prescription data. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
WRK WestRock
$35.40

1.4 (4.12%)

07/15/19
07/15/19
DOWNGRADE
Target $32

Underweight
WestRock downgraded to Underweight at KeyBanc
As previously reported, KeyBanc analyst Adam Josephson downgraded WestRock to Underweight from Sector Weight, with a $32 price target. The analyst believes his below-consensus estimates are biased downward rather than upward given worsening fundamentals in containerboard, pulp, and uncoated freesheet.
07/15/19
KEYB
07/15/19
DOWNGRADE
Target $32
KEYB
Underweight
WestRock downgraded to Underweight from Sector Weight at KeyBanc
KeyBanc analyst Adam Josephson downgraded WestRock to Underweight from Sector Weight with a $32 price target.
06/24/19
SPHN
06/24/19
DOWNGRADE
Target $60
SPHN
Equal Weight
International Paper downgraded to Equal Weight from Overweight at Stephens
Stephens analyst Mark Connelly downgraded International Paper (IP) to Equal Weight from Overweight, noting that RISI decided to cut the price of containerboard $10 "just three days after investors breathed a sigh of relief on encouraging supply-demand fundamentals." The $10 price cut triggers contract cuts as supply and demand were showing clear indications of moving back into balance thanks to supply discipline from International and WestRock (WRK), said Connelly, who sees damage being done to investor confidence by the "increasing unpredictability" of containerboard pricing. He also thinks continued new capacity announcements will keep up a high need for economic downtime, added the analyst, who keeps a $60 price target on International Paper shares.
05/15/19
UBSW
05/15/19
INITIATION
Target $47
UBSW
Buy
WestRock initiated with a Buy at UBS
UBS analyst Edlain Rodriguez initiated WestRock with a Buy rating and a price target of $47, saying the risk-reward on the stock is favorable despite the near-term decline in containerboard prices and the KapStone integration risk. The analyst also believes that the market may be "too pessimistic" in anticipating a sharp containerboard price decline coming from decelerating demand and added capacity. Rodriguez adds that the production downtime and capacity delays will likely moderate price declines to $10/ton rather than the market expectation of $40/ton.

TODAY'S FREE FLY STORIES

GM

General Motors

$35.57

0.9 (2.60%)

15:59
10/13/19
10/13
15:59
10/13/19
15:59
Periodicals
UAW boosting strike pay as General Motor walkout continues, Reuters says »

The United Auto Workers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

MRK

Merck

$84.31

0.6 (0.72%)

, JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

15:49
10/13/19
10/13
15:49
10/13/19
15:49
Periodicals
Congo to start using Johnson & Johnson Ebola vaccine next month, Reuters says »

Health authorities in…

MRK

Merck

$84.31

0.6 (0.72%)

JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 23

    Oct

  • 29

    Oct

  • 06

    Nov

  • 24

    Jan

  • 24

    Jan

  • 14

    Mar

HMTV

Hemisphere Media

$11.70

0.05 (0.43%)

15:48
10/13/19
10/13
15:48
10/13/19
15:48
Initiation
Hemisphere Media initiated  »

Hemisphere Media…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$36.11

0.31 (0.87%)

15:37
10/13/19
10/13
15:37
10/13/19
15:37
Hot Stocks
Pfizer presents Phase 3 data for Abrocitinib in moderate to severe AD »

Pfizer announced complete…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

CNCE

Concert Pharmaceuticals

$5.85

(0.00%)

15:29
10/13/19
10/13
15:29
10/13/19
15:29
Hot Stocks
Concert Pharmaceuticals presents Phase 2 data in Alopecia Areata »

Concert Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$76.14

0.38 (0.50%)

15:23
10/13/19
10/13
15:23
10/13/19
15:23
Hot Stocks
Incyte announces 52-week results from Phase 2 study of Ruxolitinib cream »

Incyte announced 52-week…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

LLY

Eli Lilly

$108.37

1.54 (1.44%)

14:15
10/13/19
10/13
14:15
10/13/19
14:15
Hot Stocks
Eli Lilly says Taltz met co-primary endpoints in Phase 3 plaque psoriasis study »

Eli Lilly announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

PCG

PG&E

$8.08

0.3 (3.86%)

07:46
10/13/19
10/13
07:46
10/13/19
07:46
Hot Stocks
PG&E says all customers impacted by safety shutoffs now have power »

Pacific Gas and Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Nov

  • 10

    Nov

  • 12

    Nov

  • 07

    Jan

BNTX

BioNTech

$13.50

-0.85 (-5.92%)

, VIR

Vir Biotechnology

$14.06

(0.00%)

07:18
10/13/19
10/13
07:18
10/13/19
07:18
On The Fly
Opening Day: BioNTech raises $150M in smaller than expected IPO »

BioNTech (BNTX) raised…

BNTX

BioNTech

$13.50

-0.85 (-5.92%)

VIR

Vir Biotechnology

$14.06

(0.00%)

HBT

HBT Financial

$15.56

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

SFTBY

SoftBank

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

KRAT

Karat Packaging

$0.00

(0.00%)

POST

Post Holdings

$101.19

1.94 (1.95%)

IPHA

Innate Pharma

$0.00

(0.00%)

BRBR

BellRing Brands

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 17

    Oct

  • 17

    Oct

ANGO

AngioDynamics

$14.54

0.12 (0.83%)

, BAYRY

Bayer

$0.00

(0.00%)

04:55
10/13/19
10/13
04:55
10/13/19
04:55
Conference/Events
Healthcare Made Practical to hold a symposium »

Symposium on Clinical…

ANGO

AngioDynamics

$14.54

0.12 (0.83%)

BAYRY

Bayer

$0.00

(0.00%)

BSX

Boston Scientific

$38.22

0.22 (0.58%)

BTG

B2Gold

$3.25

-0.2 (-5.80%)

JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

LLY

Eli Lilly

$108.37

1.54 (1.44%)

MDT

Medtronic

$107.61

0.24 (0.22%)

PFE

Pfizer

$36.11

0.31 (0.87%)

PHG

Philips

$42.88

0.99 (2.36%)

TRUMY

Terumo

$0.00

(0.00%)

VAR

Varian Medical

$110.78

1.84 (1.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 29

    Oct

  • 06

    Nov

  • 06

    Nov

  • 13

    Nov

AMBA

Ambarella

$53.62

1.25 (2.39%)

, ON

ON Semiconductor

$18.74

0.67 (3.71%)

09:31
10/12/19
10/12
09:31
10/12/19
09:31
On The Fly
Week in Review: How Trump's policies moved stocks »

Catch up on the top…

AMBA

Ambarella

$53.62

1.25 (2.39%)

ON

ON Semiconductor

$18.74

0.67 (3.71%)

AAPL

Apple

$236.21

6.12 (2.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 28

    Oct

  • 30

    Oct

BBBY

Bed Bath & Beyond

$12.98

0.89 (7.36%)

, AMZN

Amazon.com

$1,730.79

11.115 (0.65%)

08:48
10/12/19
10/12
08:48
10/12/19
08:48
Periodicals
Bed Bath & Beyond not a bargain, Barron's says »

While Bed Bath &…

BBBY

Bed Bath & Beyond

$12.98

0.89 (7.36%)

AMZN

Amazon.com

$1,730.79

11.115 (0.65%)

TGT

Target

$111.86

1.29 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 21

    Nov

SNE

Sony

$58.16

0.83 (1.45%)

, MSFT

Microsoft

$139.62

0.52 (0.37%)

08:39
10/12/19
10/12
08:39
10/12/19
08:39
Periodicals
Activision, Take-Two to benefit from next videogame cycle, Barron's says »

Sony (SNE) has announced…

SNE

Sony

$58.16

0.83 (1.45%)

MSFT

Microsoft

$139.62

0.52 (0.37%)

ATVI

Activision Blizzard

$54.80

1.1 (2.05%)

TTWO

Take-Two

$122.42

0.02 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 23

    Oct

  • 26

    Oct

  • 27

    Oct

  • 29

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

  • 13

    Nov

  • 21

    Nov

  • 21

    Nov

K

Kellogg

$62.14

-0.27 (-0.43%)

08:27
10/12/19
10/12
08:27
10/12/19
08:27
Periodicals
Kellogg stock looking like worth 'snacking on,' Barron's says »

Kellogg's stock fell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

, ITW

Illinois Tool Works

$154.56

4.68 (3.12%)

08:20
10/12/19
10/12
08:20
10/12/19
08:20
Periodicals
J&J, Pentair among stocks with sage, growing dividends, Barron's says »

Investors seeking yield…

JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

ITW

Illinois Tool Works

$154.56

4.68 (3.12%)

NUE

Nucor

$52.69

2.48 (4.94%)

PNR

Pentair

$37.33

1.215 (3.36%)

GWW

Grainger

$305.24

16.49 (5.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 25

    Oct

ANGO

AngioDynamics

$14.54

0.12 (0.83%)

, BAYRY

Bayer

$0.00

(0.00%)

04:55
10/12/19
10/12
04:55
10/12/19
04:55
Conference/Events
Healthcare Made Practical to hold a symposium »

Symposium on Clinical…

ANGO

AngioDynamics

$14.54

0.12 (0.83%)

BAYRY

Bayer

$0.00

(0.00%)

BSX

Boston Scientific

$38.22

0.22 (0.58%)

BTG

B2Gold

$3.25

-0.2 (-5.80%)

JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

LLY

Eli Lilly

$108.37

1.54 (1.44%)

MDT

Medtronic

$107.61

0.24 (0.22%)

PFE

Pfizer

$36.11

0.31 (0.87%)

PHG

Philips

$42.88

0.99 (2.36%)

TRUMY

Terumo

$0.00

(0.00%)

VAR

Varian Medical

$110.78

1.84 (1.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 29

    Oct

  • 06

    Nov

  • 06

    Nov

  • 13

    Nov

THTX

Theratechnologies

$3.76

0.01 (0.27%)

18:32
10/11/19
10/11
18:32
10/11/19
18:32
Hot Stocks
Theratechnologies: Tesamorelin study results on NAFLD published in Lancet HIV »

Theratechnologies is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEN

Wendy's

$20.76

0.76 (3.80%)

18:26
10/11/19
10/11
18:26
10/11/19
18:26
Hot Stocks
Wendy's CEO: We are really focused on the long term »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

  • 13

    Nov

GOOG

Alphabet

$1,213.86

5.88 (0.49%)

, GOOGL

Alphabet Class A

$1,214.62

6.18 (0.51%)

18:25
10/11/19
10/11
18:25
10/11/19
18:25
Periodicals
Breaking Periodicals news story on Alphabet, Alphabet Class A »

DOJ to more closely…

GOOG

Alphabet

$1,213.86

5.88 (0.49%)

GOOGL

Alphabet Class A

$1,214.62

6.18 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

BA

Boeing

$374.90

3.97 (1.07%)

18:22
10/11/19
10/11
18:22
10/11/19
18:22
Hot Stocks
Boeing board separates CEO and Chairman roles »

Boeing announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$296.34

3.1 (1.06%)

18:08
10/11/19
10/11
18:08
10/11/19
18:08
Hot Stocks
White House releases letter from China's Xi to President Trump »

The White House posted on…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$296.34

3.1 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVA

Avista

$48.73

0.51 (1.06%)

17:40
10/11/19
10/11
17:40
10/11/19
17:40
Hot Stocks
Avista reaches all-party settlement in Idaho general rate case »

Avista and all parties to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 10

    Nov

AMC

AMC Entertainment

$9.21

0.055 (0.60%)

17:10
10/11/19
10/11
17:10
10/11/19
17:10
Hot Stocks
AMC Entertainment appoints Sean Goodman CFO »

AMC Entertainment (AMC)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCEHY

Tencent

$0.00

(0.00%)

, ATVI

Activision Blizzard

$54.80

1.1 (2.05%)

17:04
10/11/19
10/11
17:04
10/11/19
17:04
Hot Stocks
Riot tells 'League of Legends' players, casters to not discuss politics on air »

John Needham, Global Head…

TCEHY

Tencent

$0.00

(0.00%)

ATVI

Activision Blizzard

$54.80

1.1 (2.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 07

    Nov

CLNC

Colony Credit Real Estate

$14.02

0.12 (0.86%)

16:55
10/11/19
10/11
16:55
10/11/19
16:55
Syndicate
Colony Credit Real Estate files to sell 47.94M shares of Class A common stock »

The offering is being…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.